Preoperative Evaluation and Management of Patients With Select Chronic Gastrointestinal, Liver, and Renal Diseases

Wiesmann T. Kranke P. Eberhart L.

Postoperative nausea and vomiting — a narrative review of pathophysiology, pharmacotherapy and clinical management strategies.

Expert Opin Pharmacother. 16: 1069-1077VandeHei M.S. Papageorge C.M. Murphy M.M. Kennedy G.D.

The effect of perioperative fluid management on postoperative ileus in rectal cancer patients.

Surgery. 161: 1628-1632Nisanevich V. Felsenstein I. Almogy G. Weissman C. Einav S. Matot I.

Effect of intraoperative fluid management on outcome after intraabdominal surgery.

Anesthesiology. 103: 25-32Lobo D.N. Bostock K.A. Neal K.R. Perkins A.C. Rowlands B.J. Allison S.P.

Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial.

Lancet. 359: 1812-1818Hunter J.M. Parker C.J. Bell C.F. Jones R.S. Utting J.E.

The use of different doses of vecuronium in patients with liver dysfunction.

Br J Anaesth. 57: 758-764Magorian T. Wood P. Caldwell J. et al.

The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease.

Anesth Analg. 80: 754-759Northup P.G. Friedman L.S. Kamath P.S.

AGA clinical practice update on surgical risk assessment and perioperative management in cirrhosis: expert review.

Clin Gastroenterol Hepatol. 17: 595-606

The risk of surgery in patients with liver disease.

Hepatology. 29: 1617-1623Harville D.D. Summerskill W.H.

Surgery in acute hepatitis. Causes and effects.

JAMA. 184: 257-261Greenwood S.M. Leffler C.T. Minkowitz S.

The increased mortality rate of open liver biopsy in alcoholic hepatitis.

Surg Gynecol Obstet. 134: 600-604Powell-Jackson P. Greenway B. Williams R.

Adverse effects of exploratory laparotomy in patients with unsuspected liver disease.

Br J Surg. 69: 449-451Lee W.M. Stravitz R.T. Larson A.M.

Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.

Hepatology. 55: 965-967

Perioperative risk assessment for patients with cirrhosis and liver disease.

Expert Rev Gastroenterol Hepatol. 3: 65-75

Surgical procedures are well tolerated by patients with asymptomatic chronic hepatitis.

J Clin Gastroenterol. 8: 542-544Cheung R.C. Hsieh F. Wang Y. Pollard J.B.

The impact of hepatitis C status on postoperative outcome.

Anesth Analg. 97: 550-554O'Leary J.G. Yachimski P.S. Friedman L.S.

Surgery in the patient with liver disease.

Clin Liver Dis. 13: 211-231Villanova N. Moscatiello S. Ramilli S. et al.

Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

Hepatology. 42: 473-480

Risk stratification and preoperative evaluation of the patient with known or suspected liver disease.

Clin Liver Dis (Hoboken). 7: 101-105Huxtable C.A. Roberts L.J. Somogyi A.A. MacIntyre P.E.

Acute pain management in opioid-tolerant patients: a growing challenge.

Anaesth Intensive Care. 39: 804-823Yarze J.C. Martin P. Munoz S.J. Friedman L.S.

Wilson's disease: current status.

Am J Med. 92: 643-654Bacon B.R. Adams P.C. Kowdley K.V. et al.

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Hepatology. 54: 328-343Higashi H. Matsumata T. Adachi E. Taketomi A. Kashiwagi S. Sugimachi K.

Influence of viral hepatitis status on operative morbidity and mortality in patients with primary hepatocellular carcinoma.

Br J Surg. 81: 1342-1345Raslau D. Bierle D.M. Stephenson C.R. Mikhail M.A. Kebede E.B. Mauck K.F.

Preoperative cardiac risk assessment.

Mayo Clin Proc. 95: 1064-1079O'Rourke M.J. Keshock M.C. Boxhorn C.E. et al.

Preoperative management of opioid and nonopioid analgesics: Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus statement.

Mayo Clin Proc. 96: 1325-1341Parikh N.D. Chang Y.H. Tapper E.B. Mathur A.K.

Outcomes of patients with cirrhosis undergoing orthopedic procedures: an analysis of the Nationwide Inpatient Sample.

J Clin Gastroenterol. 53: e356-e361Teh S.H. Nagorney D.M. Stevens S.R. et al.

Risk factors for mortality after surgery in patients with cirrhosis.

Gastroenterology. 132: 1261-1269Chalasani N. Younossi Z. Lavine J.E. et al.

The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.

Hepatology. 67: 328-357Pugh R.N. Murray-Lyon I.M. Dawson J.L. Pietroni M.C. Williams R.

Transection of the oesophagus for bleeding oesophageal varices.

Br J Surg. 60: 646-649Malinchoc M. Kamath P.S. Gordon F.D. Peine C.J. Rank J. ter Borg P.C.

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Hepatology. 31: 864-871Ziser A. Plevak D.J. Wiesner R.H. Rakela J. Offord K.P. Brown D.L.

Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery.

Anesthesiology. 90: 42-53Runyon B.A. AASLD Practice Guidelines Committee

Management of adult patients with ascites due to cirrhosis: an update.

Hepatology. 49: 2087-2107O'Leary J.G. Greenberg C.S. Patton H.M. Caldwell S.H.

AGA Clinical practice update: coagulation in cirrhosis.

Gastroenterology. 157: 34-43.e31Tripodi A. Salerno F. Chantarangkul V. et al.

Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.

Hepatology. 41: 553-558Tripodi A. Primignani M. Chantarangkul V. et al.

Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.

Liver Int. 33: 362-367Forkin K.T. Colquhoun D.A. Nemergut E.C. Huffmyer J.L.

The coagulation profile of end-stage liver disease and considerations for intraoperative management.

Anesth Analg. 126: 46-61Lisman T. Bongers T.N. Adelmeijer J. et al.

Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.

Hepatology. 44: 53-61Drolz A. Horvatits T. Roedl K. et al.

Coagulation parameters and major bleeding in critically ill patients with cirrhosis.

Hepatology. 64: 556-568Ambrosino P. Tarantino L. Di Minno G. et al.

The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis.

Thromb Haemost. 117: 139-148Anderson D.R. Morgano G.P. Bennett C. et al.

American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.

Blood Adv. 3: 3898-3944Vilstrup H. Amodio P. Bajaj J. et al.

Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Hepatology. 60: 715-735Plauth M. Bernal W. Dasarathy S. et al.

ESPEN guideline on clinical nutrition in liver disease.

Clin Nutr. 38: 485-521Navarro L.H. Bloomstone J.A. Auler Jr., J.O. et al.

Perioperative fluid therapy: a statement from the international Fluid Optimization Group.

Perioper Med (Lond). 4: 3

Reply: to PMID 23281277.

Liver Transpl. 19: 672Lazarev M. Ullman T. Schraut W.H. Kip K.E. Saul M. Regueiro M.

Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center.

Inflamm Bowel Dis. 16: 830-835

Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new “biological era.”.

Gastroenterol Rep (Oxf). 5: 165-177Froessler B. Palm P. Weber I. Hodyl N.A. Singh R. Murphy E.M.

The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial.

Ann Surg. 264: 41-46Richards T. Baikady R.R. Clevenger B. et al.

Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.

Lancet. 396: 1353-1361Gould M.K. Garcia D.A. Wren S.M. et al.

Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Chest. 141: e227S-e277SFalck-Ytter Y. Francis C.W. Johanson N.A. et al.

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Chest. 141: e278S-e325SBurr N.E. Smith C. West R. Hull M.A. Subramanian V.

Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England.

Clin Gastroenterol Hepatol. 16: 534-541.e6Beddy D. Dozois E.J. Pemberton J.H.

Perioperative complications in inflammatory bowel disease.

Inflamm Bowel Dis. 17: 1610-1619Nickerson T.P. Merchea A.

Perioperative considerations in crohn disease and ulcerative colitis.

Clin Colon Rectal Surg. 29: 80-84Pfeifer K.J. Selzer A. Whinney C.M. et al.

Preoperative management of gastrointestinal and pulmonary medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus statement.

Mayo Clin Proc. 96: 3158-3177Sun L.Y. Wijeysundera D.N. Tait G.A. Beattie W.S.

Association of intraoperative hypotension with acute kidney injury after elective noncardiac surgery.

Anesthesiology. 123: 515-523Butterworth J.F.M.D. Wasnick J.D.

Morgan and Mikhail's Clinical Anesthesiology.

5 ed. McGraw-Hill, New York, New YorkProwle J.R. Chua H.R. Bagshaw S.M. Bellomo R.

Clinical review: volume of fluid resuscitation and the incidence of acute kidney injury — a systematic review.

Crit Care. 16: 230

Intraoperative fluid management: past and future, where is the evidence?.

Saudi J Anaesth. 12: 311-317Stephenson C. Mohabbat A. Raslau D. Gilman E. Wight E. Kashiwagi D.

Management of common postoperative complications.

Mayo Clin Proc. 95: 2540-2554

Erratum Regarding “US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States” (Am J Kidney Dis. 2018;71[3][suppl 1]:Svii,S1-S676).

Am J Kidney Dis. 71: 501Gajdos C. Hawn M.T. Kile D. et al.

The risk of major elective vascular surgical procedures in patients with end-stage renal disease.

Ann Surg. 257: 766-773

Mortality and complications after hip fracture among elderly patients undergoing hemodialysis.

BMC Nephrol. 16: 100Moran-Atkin E. Stem M. Lidor A.O.

Surgery for diverticulitis is associated with high risk of in-hospital mortality and morbidity in older patients with end-stage renal disease.

Surgery. 156: 361-370Parikh D.S. Swaminathan M. Archer L.E. et al.

Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA.

Nephrol Dial Transplant. 25: 2275-2283Brakoniecki K. Tam S. Chung P. Smith M. Alfonso A. Sugiyama G.

Mortality in patients with end-stage renal disease and the risk of returning to the operating room after common general surgery procedures.

Am J Surg. 213: 395-398Shemin D. Bostom A.G. Laliberty P. Dworkin L.D.

Residual renal function and mortality risk in hemodialysis patients.

Am J Kidney Dis. 38: 85-90Carlo J.O. Phisitkul P. Phisitkul K. Reddy S. Amendola A.

Perioperative implications of end-stage renal disease in orthopaedic surgery.

J Am Acad Orthop Surg. 23: 107-118Kanda H. Hirasaki Y. Iida T. et al.

Perioperative management of patients with end-stage renal disease.

J Cardiothorac Vasc Anesth. 31: 2251-2267

Sanghani NS, Soundararajan R, Golper TA. Medical management of the dialysis patient undergoing surgery. In:Post TW, ed. UptoDate. UpToDate. Accessed February 20, 2020. https://www.uptodate.com/contents/medical-management-of-the-dialysis-patient-undergoing-surgery

Kleinpeter M.A. Krane N.K.

Perioperative management of peritoneal dialysis patients: review of abdominal surgery.

Adv Perit Dial. 22: 119-123

Hyperkalemia in dialysis patients.

Semin Dial. 14: 348-356

The risk of preoperative hyperkalemia.

Semin Dial. 16: 78-79Hedges S.J. Dehoney S.B. Hooper J.S. Amanzadeh J. Busti A.J.

Evidence-based treatment recommendations for uremic bleeding.

Nat Clin Pract Nephrol. 3: 138-153Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group

KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.

Kidney Int. 3: 1-150Boccardo P. Remuzzi G. Galbusera M.

Platelet dysfunction in renal failure.

Semin Thromb Hemost. 30: 579-589Acedillo R.R. Shah M. Devereaux P.J. et al.

The risk of perioperative bleeding in patients with chronic kidney disease: a systematic review and meta-analysis.

Ann Surg. 258: 901-913Lee H.K. Kim Y.J. Jeong J.U. Park J.S. Chi H.S. Kim S.B.

Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.

Nephron Clin Pract. 114: 248-252Mannucci P.M. Remuzzi G. Pusineri F. et al.

Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

N Engl J Med. 308: 8-12

Pharmacologic methods to reduce perioperative bleeding.

Transfusion. 48: 31S-38STrainor D. Borthwick E. Ferguson A.

Perioperative management of the hemodialysis patient.

Semin Dial. 24: 314-326Evans D.C. Martindale R.G. Kiraly L.N. Jones C.M.

Nutrition optimization prior to surgery.

Nutr Clin Pract. 29: 10-21Weimann A. Braga M. Carli F. et al.

ESPEN guideline: clinical nutrition in surgery.

Clin Nutr. 36: 623-650Sabatino A. Regolisti G. Karupaiah T. et al.

Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis.

Clin Nutr. 36: 663-671

留言 (0)

沒有登入
gif